Cyclica

Cyclica is a biotechnology company that utilizes AI and computational biophysics for drug discovery activities. The Cyclica platform is supported by proprietary deep learning proteome screening technology, MatchMaker™, and an innovative supervised learning technique for predicting molecular properties, POEM™. The platform can simultaneously prioritize compounds based on their target and non-target polypharmacological profiles as well as their developmental characteristics, making it suitable for designing novel drug-like chemicals.